Research ArticleMinireview
G-Protein–Coupled Receptor Kinase 2 as a Potential Modulator of the Hallmarks of Cancer
Laura Nogués, Clara Reglero, Verónica Rivas, María Neves, Petronila Penela and Federico Mayor Jr.
Molecular Pharmacology March 2017, 91 (3) 220-228; DOI: https://doi.org/10.1124/mol.116.107185
Laura Nogués
Departamento de Biología Molecular and Centro de Biología Molecular “Severo Ochoa,” Universidad Autónoma de Madrid (L.N., C.R., V.R., M.N., P.P., F.M), and Instituto de Investigación Sanitaria La Princesa (L.N., C.R., V.R., P.P., F.M.), Madrid, Spain
Clara Reglero
Departamento de Biología Molecular and Centro de Biología Molecular “Severo Ochoa,” Universidad Autónoma de Madrid (L.N., C.R., V.R., M.N., P.P., F.M), and Instituto de Investigación Sanitaria La Princesa (L.N., C.R., V.R., P.P., F.M.), Madrid, Spain
Verónica Rivas
Departamento de Biología Molecular and Centro de Biología Molecular “Severo Ochoa,” Universidad Autónoma de Madrid (L.N., C.R., V.R., M.N., P.P., F.M), and Instituto de Investigación Sanitaria La Princesa (L.N., C.R., V.R., P.P., F.M.), Madrid, Spain
María Neves
Departamento de Biología Molecular and Centro de Biología Molecular “Severo Ochoa,” Universidad Autónoma de Madrid (L.N., C.R., V.R., M.N., P.P., F.M), and Instituto de Investigación Sanitaria La Princesa (L.N., C.R., V.R., P.P., F.M.), Madrid, Spain
Petronila Penela
Departamento de Biología Molecular and Centro de Biología Molecular “Severo Ochoa,” Universidad Autónoma de Madrid (L.N., C.R., V.R., M.N., P.P., F.M), and Instituto de Investigación Sanitaria La Princesa (L.N., C.R., V.R., P.P., F.M.), Madrid, Spain
Federico Mayor Jr.
Departamento de Biología Molecular and Centro de Biología Molecular “Severo Ochoa,” Universidad Autónoma de Madrid (L.N., C.R., V.R., M.N., P.P., F.M), and Instituto de Investigación Sanitaria La Princesa (L.N., C.R., V.R., P.P., F.M.), Madrid, Spain

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleMinireview
GRK2 as an Oncomodulator
Laura Nogués, Clara Reglero, Verónica Rivas, María Neves, Petronila Penela and Federico Mayor
Molecular Pharmacology March 1, 2017, 91 (3) 220-228; DOI: https://doi.org/10.1124/mol.116.107185
Jump to section
- Article
- Abstract
- Introduction
- Canonical and Noncanonical Roles of GRK2
- GRK2 Regulates Cell Proliferation and Survival Cascades
- GRK2 Modulates Immune and Epithelial Cell Motility
- GRK2 Modulates Key Cell Metabolism Networks
- GRK2 Roles in Tumoral Angiogenesis and in the Proinflammatory Tumor Microenvironment
- Changes in GRK2 Expression/Activity in Specific Tumors and Functional Impact
- Concluding Remarks
- Acknowledgments
- Authorship Contributions
- Footnotes
- Abbreviations
- References
- Figures & Data
- Info & Metrics
- eLetters
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement